Aerobic Exercise, Essential Hypertension
Conditions
Keywords
supervised aerobic exercise, functional capacity, quality of life, depression level, essential hypertension
Brief summary
The goal of this observational study is to evaluate the effects of a supervised aerobic exercise training program on weight loss, functional capacity, quality of life (QoL), and depression levels in patients with essential hypertension.
Detailed description
Patients who chose the treatment type according to personal preferences were divided into two groups: Group 1(n:91) exercised for six weeks, five sessions per week under the supervision of a medical doctor in the aerobic exercise laboratory, and group 2(n:47) was advised to maintain dietary habits and physical activity levels. Body weight, serum lipid levels, functional capacity, QoL, and depression level of all the participants were evaluated at baseline and 6 weeks later.
Interventions
Group 1 exercised for six weeks, five sessions per week under the supervision of a medical doctor in the aerobic exercise laboratory.
Sponsors
TC Erciyes University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Over 18 years of age, * Absence of concomitant other metabolic and cardiovascular diseases.
Exclusion criteria
* Having suffered an event of ischaemic heart disease (\<6 months), * Secondary hypertension, * Hypertrophic obstructive cardiomyopathy, * Congestive heart failure, * Uncontrolled cardiac arrhythmia, * Thyroid dysfunction, * Diabetes mellitus, * Symptomatic peripheral arterial occlusive disease, * Aortic insufficiency or stenosis, * Pulmonary or heart disease with dyspnoea at small or moderate effort, * An outbreak of orthopedic problems on hip, knee or ankles, such as arthroplasty, contracture or severe osteoarthritis, * Using of antidepressant or anxiolytic drugs, * Pregnancy, * Cognitive disfunction.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Body weight | was measured at the pre-treatment period and the post-treatment 6th week for all the participants by the same physician. | kilograms |
| Blood samples | Twelve-hour fasting blood samples were collected between 6.00 am, and 10.00 am at baseline and week 6. | Serum total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, and triglycerides |
| The functional capacity | 6MWT was assessed in face-to-face interviews before and immediately after the treatment was completed. | The 6MWT test and the estimated metabolic equivalents or METs were used performed to evaluate functional capacity. |
| Quality of Life | SF36 was assessed in face-to-face interviews before and immediately after the treatment was completed. | Quality of life was assessed with Short Form-36 (SF-36). |
| Depression level | BDI was assessed in face-to-face interviews before and immediately after the treatment was completed. | Depression level was assessed Beck Depression Inventory (BDI). |
Countries
Turkey (Türkiye)
Outcome results
None listed